Inositol lipid phosphatases in membrane trafficking and human disease

Biochemical Journal

Volumn 461, Issue 2, 2014, Pages 159-175

  Billcliff, Peter G ^a   Lowe, Martin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Endocytosis; Human disease; Inositol phosphatase; Membrane traffic; Phosphoinositide; Secretory pathway

Indexed keywords

INOSITOL; INOSITOL LIPID PHOSPHATASE; INOSITOL POLYPHOSPHATE; INOSITOL POLYPHOSPHATE 3 PHOSPHATASE; INOSITOL POLYPHOSPHATE 4 PHOSPHATASE; LIPID; MYOTUBULARIN; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROLINE RICH INOSITOL POLYPHOSPHATE 5 PHOSPHATASE; PROTEIN; SAC PHOSPHATASE; SAC1 PHOSPHATASE; SAC2 PHOSPHATASE; SAC3 PHOSPHATASE; SHIP1 PROTEIN; SHIP2 PROTEIN; SYNAPTOJANIN; UNCLASSIFIED DRUG;

ASTHMA; CELLULAR DISTRIBUTION; DISEASES; DOWN SYNDROME; GENE; HUMAN; JOUBERT SYNDROME; LOWE SYNDROME; MEMBRANE; MUSCLE ATROPHY; NEOPLASM; NEUROLOGIC DISEASE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OCRL1 GENE; PARKINSONISM; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TEMPORAL LOBE EPILEPSY; VARIANT CREUTZFELDT JAKOB DISEASE;

ASTHMA; BIOLOGICAL TRANSPORT; HUMANS; NEOPLASMS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84903315590     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140361     Document Type: Review

References (189)

1. Di Paolo, G. and De Camilli, P. (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657 CrossRef PubMed (Pubitemid 44564702)
2. Balla, T. (2013) Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 93, 1019-1137 CrossRef PubMed
3. Suh, B.-C. and Hille, B. (2005) Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr. Opin. Neurobiol. 15, 370-378 CrossRef PubMed (Pubitemid 40806451)
4. Hakim, S., Bertucci, M., Conduit, S., Vuong, D. and Mitchell, C. (2012) Inositol polyphosphate phosphatases in human disease. In Phosphoinositides and Disease (Falasca, M., ed.), pp. 247-314, Springer, Dordrecht CrossRef
5. McCrea, H. J. and De Camilli, P. (2009) Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology 24, 8-16 CrossRef PubMed
6. Ooms, L. M., Horan, K. A., Rahman, P., Seaton, G., Gurung, R., Kethesparan, D. S. and Mitchell, C. A. (2009) The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 419, 29-49 CrossRef PubMed
7. Liu, Y. and Bankaitis, V. A. (2010) Phosphoinositide phosphatases in cell biology and disease. Prog. Lipid Res. 49, 201-217 CrossRef PubMed
8. De Matteis, M. A., Wilson, C. and D'Angelo, G. (2013) Phosphatidylinositol-4-phosphate: the Golgi and beyond. BioEssays 35, 612-622 CrossRef PubMed
9. Cullen, P. J. and Carlton, J. G. (2012) Phosphoinositides in the mammalian endo-lysosomal network. In Phosphoinositides II: the Diverse Biological Functions (Balla, T., Wymann, M. and York, J. D., eds), pp. 65-110, Springer, Dordrecht CrossRef
10. McMahon, H. T. and Boucrot, E. (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12, 517-533 CrossRef PubMed
11. Posor, Y., Eichhorn-Gruenig, M., Puchkov, D., Scho̊neberg, J., Ullrich, A., Lampe, A., Můller, R., Zarbakhsh, S., Gulluni, F., Hirsch, E. et al. (2013) Spatiotemporal control of endocytosis by phosphatidylinositol-3, 4-bisphosphate. Nature 499, 233-237 CrossRef PubMed
12. Yeung, T., Ozdamar, B., Paroutis, P. and Grinstein, S. (2006) Lipid metabolism and dynamics during phagocytosis. Curr. Opin. Cell Biol. 18, 429-437 CrossRef PubMed (Pubitemid 44016055)
13. Schink, K. O., Raiborg, C. and Stenmark, H. (2013) Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling. BioEssays 35, 900-912 PubMed
14. Ho, C. Y., Alghamdi, T. A. and Botelho, R. J. (2012) Phosphatidylinositol-3,5-bisphosphate: no longer the poor PIP2. Traffic 13, 1-8 CrossRef PubMed
15. Viaud, J., Boal, F., Tronchère, H., Gaits-Iacovoni, F. and Payrastre, B. (2013) Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics. BioEssays, doi:10.1002/bies.20130132 CrossRef
16. Hnia, K., Vaccari, I., Bolino, A. and Laporte, J. (2012) Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol. Med. 18, 317-327 CrossRef PubMed
17. Gupta, V. A., Hnia, K., Smith, L. L., Gundry, S. R., McIntire, J. E., Shimazu, J., Bass, J. R., Talbot, E. A., Amoasii, L., Goldman, N. E. et al. (2013) Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish. PLoS Genet. 9, e1003583 CrossRef PubMed
18. Cao, C., Backer, J. M., Laporte, J., Bedrick, E. J. and Wandinger-Ness, A. (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol. Biol. Cell 19, 3334-3346 CrossRef PubMed
19. Cao, C., Laporte, J., Backer, J. M., Wandinger-Ness, A. and Stein, M.-P. (2007) Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8, 1052-1067 CrossRef PubMed (Pubitemid 47074038)
20. Lee, H. W., Kim, Y., Han, K., Kim, H. and Kim, E. (2010) The phosphoinositide 3-phosphatase MTMR2 interacts with PSD-95 and maintains excitatory synapses by modulating endosomal traffic. J. Neurosci. 30, 5508-5518 CrossRef PubMed
21. Franklin, N. E., Taylor, G. S. and Vacratsis, P. O. (2011) Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is regulated by an N-terminal phosphorylation site. J. Biol. Chem. 286, 15841-15853 CrossRef PubMed
22. Taylor, G. S., Maehama, T. and Dixon, J. E. (2000) Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. U.S.A. 97, 8910-8915 CrossRef PubMed (Pubitemid 30626647)
23. Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B. and Mandel, J. L. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet. 9, 2223-2229 CrossRef PubMed
24. Laporte, J., Liaubet, L., Blondeau, F., Tronchère, H., Mandel, J.-L. and Payrastre, B. (2002) Functional redundancy in the myotubularin family. Biochem. Biophys. Res. Commun. 291, 305-312 CrossRef PubMed (Pubitemid 34694405)
25. Chaussade, C., Pirola, L., Bonnafous, S., Blondeau, F., Brenz-Verca, S., Tronchère, H., Portis, F., Rusconi, S., Payrastre, B., Laporte, J. and Van Obberghen, E. (2003) Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol. Endocrinol. 17, 2448-2460 CrossRef PubMed (Pubitemid 37542209)
26. Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C. and Kiger, A. A. (2010) Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J. Cell Biol. 190, 407-425 CrossRef PubMed
27. Ribeiro, I., Yuan, L., Tanentzapf, G., Dowling, J. J. and Kiger, A. (2011) Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance. PLoS Genet. 7, e1001295 CrossRef PubMed
28. Naughtin, M. J., Sheffield, D. A., Rahman, P., Hughes, W. E., Gurung, R., Stow, J. L., Nandurkar, H. H., Dyson, J. M. and Mitchell, C. A. (2010) The myotubularin phosphatase MTMR4 regulates sorting from early endosomes. J. Cell Sci. 123, 3071-3083 CrossRef PubMed
29. Yu, J., Pan, L., Qin, X., Chen, H., Xu, Y., Chen, Y. and Tang, H. (2010) MTMR4 attenuates transforming growth factor β (TGFβ) signaling by dephosphorylating R-Smads in endosomes. J. Biol. Chem. 285, 8454-8462 CrossRef PubMed
30. Laporte, J., Biancalana, V., Tanner, S. M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S. and Mandel, J.-L. (2000) MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat. 15, 393-409 CrossRef PubMed (Pubitemid 30331212)
31. Royer, B., Hnia, K., Gavriilidis, C., Tronchere, H., Tosch, V. and Laporte, J. (2013) The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies. EMBO Rep. 14, 907-915 CrossRef PubMed
32. Simons, M. and Trotter, J. (2007) Wrapping it up: the cell biology of myelination. Curr. Opin. Neurobiol. 17, 533-540 CrossRef PubMed
33. Bolino, A., Bolis, A., Previtali, S. C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D. D., Feltri, M. L. et al. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol. 167, 711-721 CrossRef PubMed (Pubitemid 39565151)
34. Bolino, A., Muglia, M., Conforti, F. L., LeGuern, E., Salih, M. A. M., Georgiou, D. M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A. et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25, 17-19 CrossRef PubMed (Pubitemid 30257029)
35. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.-P., Schorle, H., Rudnik-Schöneborn, S., Büttner, R., Buchheim, E. and Zerres, K. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12, 349-356 CrossRef PubMed (Pubitemid 36204431)
36. Chow, C. Y., Zhang, Y., Dowling, J. J., Jin, N., Adamska, M., Shiga, K., Szigeti, K., Shy, M. E., Li, J., Zhang, X. et al. (2007) Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448, 68-72 CrossRef PubMed (Pubitemid 47036999)
37. Dall'Armi, C., Devereaux, K. A. and Di Paolo, G. (2013) The role of lipids in the control of autophagy. Curr. Biol. 23, R33-R45 CrossRef PubMed
38. Vergne, I. and Deretic, V. (2010) The role of PI3P phosphatases in the regulation of autophagy. FEBS Lett. 584, 1313-1318 CrossRef PubMed
39. Tosch, V., Rohde, H. M., Tronchère, H., Zanoteli, E., Monroy, N., Kretz, C., Dondaine, N., Payrastre, B., Mandel, J.-L. and Laporte, J. (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum. Mol. Genet. 15, 3098-3106 CrossRef PubMed (Pubitemid 44605492)
40. Vergne, I., Roberts, E., Elmaoued, R. A., Tosch, V., Delgado, M. A., Proikas-Cezanne, T., Laporte, J. and Deretic, V. (2009) Control of autophagy initiation by phosphoinositide 3-phosphatase jumpy. EMBO J. 28, 2244-2258 CrossRef PubMed
41. Cebollero, E., van der Vaart, A., Zhao, M., Rieter, E., Klionsky, D. J., Helms, J. B. and Reggiori, F. (2012) Phosphatidylinositol-3-phosphate clearance plays a key role in autophagosome completion. Curr. Biol. 22, 1545-1553 CrossRef PubMed
42. Song, M. S., Salmena, L. and Pandolfi, P. P. (2012) The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 PubMed
43. Martin-Belmonte, F., Gassama, A., Datta, A., Yu, W., Rescher, U., Gerke, V. and Mostov, K. (2007) PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128, 383-397 CrossRef PubMed (Pubitemid 46123512)
44. Kim, J. S., Peng, X., De, P. K., Geahlen, R. L. and Durden, D. L. (2002) PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. Blood 99, 694-697 CrossRef PubMed (Pubitemid 34533110)
45. Arico, S., Petiot, A., Bauvy, C., Dubbelhuis, P. F., Meijer, A. J., Codogno, P. and Ogier-Denis, E. (2001) The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 276, 35243-35246 CrossRef PubMed
46. Norris, F. A. and Majerus, P. W. (1994) Hydrolysis of phosphatidylinositol 3,4-bisphosphate by inositol polyphosphate 4-phosphatase isolated by affinity elution chromatography. J. Biol. Chem. 269, 8716-8720 PubMed (Pubitemid 24209178)
47. Norris, F. A., Atkins, R. C. and Majerus, P. W. (1997) The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II: evidence for conserved alternative splicing in the 4-phosphatase family. J. Biol. Chem. 272, 23859-23864 CrossRef PubMed (Pubitemid 27410966)
48. Ungewickell, A., Hugge, C., Kisseleva, M., Chang, S.-C., Zou, J., Feng, Y., Galyov, E. E., Wilson, M. and Majerus, P. W. (2005) The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. Proc. Natl. Acad. Sci. U.S.A. 102, 18854-18859 CrossRef PubMed (Pubitemid 43049531)
49. Rynkiewicz, N. K., Liu, H.-J., Balamatsias, D. and Mitchell, C. A. (2012) INPP4A/INPP4B and P-Rex proteins: related but different? Adv. Biol. Regul. 52, 265-279 CrossRef
50. Ivetac, I., Munday, A. D., Kisseleva, M. V., Zhang, X.-M., Luff, S., Tiganis, T., Whisstock, J. C., Rowe, T., Majerus, P. W. and Mitchell, C. A. (2005) The type Iα inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane. Mol. Biol. Cell 16, 2218-2233 CrossRef PubMed (Pubitemid 40632207)
51. Shin, H.-W., Hayashi, M., Christoforidis, S., Lacas-Gervais, S., Hoepfner, S., Wenk, M. R., Modregger, J., Uttenweiler-Joseph, S., Wilm, M., Nystuen, A. et al. (2005) An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J. Cell Biol. 170, 607-618 CrossRef PubMed (Pubitemid 41186935)
52. Sasaki, J., Kofuji, S., Itoh, R., Momiyama, T., Takayama, K., Murakami, H., Chida, S., Tsuya, Y., Takasuga, S., Eguchi, S. et al. (2010) The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death. Nature 465, 497-501 CrossRef PubMed
53. Nystuen, A., Legare, M. E., Shultz, L. D. and Frankel, W. N. (2001) A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice. Neuron 32, 203-212 CrossRef PubMed (Pubitemid 33030189)
54. Sachs, A. J., David, S. A., Haider, N. B. and Nystuen, A. M. (2009) Patterned neuroprotection in the Inpp4awbl mutant mouse cerebellum correlates with the expression of Eaat4. PLoS ONE 4, e8270 CrossRef PubMed
55. Karayiorgou, M., Simon, T. J. and Gogos, J. A. (2010) 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 11, 402-416 CrossRef PubMed
56. Wang, L., Luo, J., Fang, M., Jiang, G., Zhang, X., Yu, W. and Wang, X. (2012) A new trick of INPP4A: decreased expression of INPP4A in patients with temporal lobe epilepsy and pilocarpine-induced rat model. Synapse 66, 533-541 CrossRef PubMed
57. Ivetac, I., Gurung, R., Hakim, S., Horan, K. A., Sheffield, D. A., Binge, L. C., Majerus, P. W., Tiganis, T. and Mitchell, C. A. (2009) Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. EMBO Rep. 10, 487-493 CrossRef PubMed
58. Sharma, M., Batra, J., Mabalirajan, U., Sharma, S., Nagarkatti, R., Aich, J., Sharma, S. K., Niphadkar, P. V. and Ghosh, B. (2008) A genetic variation in inositol polyphosphate 4 phosphatase A enhances susceptibility to asthma. Am. J. Respir. Crit. Care Med. 177, 712-719 CrossRef PubMed (Pubitemid 351490558)
59. Ferron, M. and Vacher, J. (2006) Characterization of the murine Inpp4b gene and identification of a novel isoform. Gene 376, 152-161 CrossRef PubMed (Pubitemid 43903577)
60. Bertucci, M. C. and Mitchell, C. A. (2013) Phosphoinositide 3-kinase and INPP4B in human breast cancer. Ann. N.Y. Acad. Sci. 1280, 1-5 CrossRef PubMed
61. Ferron, M., Boudiffa, M., Arsenault, M., Rached, M., Pata, M., Giroux, S., Elfassihi, L., Kisseleva, M., Majerus, P. W., Rousseau, F. and Vacher, J. (2011) Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans. Cell Metab. 14, 466-477 CrossRef PubMed
62. Guo, S., Stolz, L. E., Lemrow, S. M. and York, J. D. (1999) SAC1-like domains of yeast SAC1,INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J. Biol. Chem. 274, 12990-12995 CrossRef PubMed
63. Attree, O., Olivos, I. M., Okabe, I., Bailey, L. C., Nelson, D. L., Lewis, R. A., McLnnes, R. R. and Nussbaum, R. L. (1992) The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358, 239-242 CrossRef PubMed
64. Hoopes, Jr, R. R., Shrimpton, A. E., Knohl, S. J., Hueber, P., Hoppe, B., Matyus, J., Simckes, A., Tasic, V., Toenshoff, B., Suchy, S. F. et al. (2005) Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76, 260-267 CrossRef PubMed (Pubitemid 40129552)
65. Jänne, P. A., Suchy, S. F., Bernard, D., MacDonald, M., Crawley, J., Grinberg, A., Wynshaw-Boris, A., Westphal, H. and Nussbaum, R. L. (1998) Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J. Clin. Invest. 101, 2042-2053 CrossRef PubMed
66. Schroer, R. J., Beaudet, A. L., Shinawi, M., Sahoo, T., Patel, A., Sun, Q., Skinner, C. and Stevenson, R. E. (2012) Duplication of OCRL and adjacent genes associated with autism but not Lowe syndrome. Am. J. Med. Genet. A. 158A, 2602-2605 CrossRef PubMed
67. Pirruccello, M. and De Camilli, P. (2012) Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem. Sci. 37, 134-143 CrossRef PubMed
68. Mehta, Z. B., Pietka, G. and Lowe, M. (2014) The cellular and physiological functions of the Lowe syndrome protein OCRL1. Traffic 15, 471-487 CrossRef PubMed
69. Schmid, A. C., Wise, H. M., Mitchell, C. A., Nussbaum, R. and Woscholski, R. (2004) Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett. 576, 9-13 CrossRef PubMed (Pubitemid 39330448)
70. Choudhury, R., Diao, A., Zhang, F., Eisenberg, E., Saint-Pol, A., Williams, C., Konstantakopoulos, A., Lucocq, J., Johannes, L., Rabouille, C. et al. (2005) Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol. Biol. Cell 16, 3467-3479 CrossRef PubMed (Pubitemid 41077061)
71. Vicinanza, M., Di Campli, A., Polishchuk, E., Santoro, M., Di Tullio, G., Godi, A., Levtchenko, E., De Leo, M. G., Polishchuk, R., Sandoval, L. et al. (2011) OCRL controls trafficking through early endosomes via PtdIns4,5P2-dependent regulation of endosomal actin. EMBO J. 30, 4970-4985 CrossRef PubMed
72. van Rahden, V. A., Brand, K., Najm, J., Heeren, J., Pfeffer, S. R., Braulke, T. and Kutsche, K. (2012) The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module. Hum. Mol. Genet. 21, 5019-5038 CrossRef PubMed
73. Rodriguez-Gabin, A. G., Ortiz, E., Demoliner, K., Si, Q., Almazan, G. and Larocca, J. N. (2010) Interaction of Rab31 and OCRL-1 in oligodendrocytes: its role in transport of mannose 6-phosphate receptors. J. Neurosci. Res. 88, 589-604 PubMed
74. Wenk, M. R., Lucast, L., Di Paolo, G., Romanelli, A. J., Suchy, S. F., Nussbaum, R. L., Cline, G. W., Shulman, G. I., McMurray, W. and De Camilli, P. (2003) Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat. Biotechnol. 21, 813-817 CrossRef PubMed (Pubitemid 36791402)
75. Ramirez, I. B.-R., Pietka, G., Jones, D. R., Divecha, N., Alia, A., Baraban, S. C., Hurlstone, A. F. L. and Lowe, M. (2012) Impaired neural development in a zebrafish model for Lowe syndrome. Hum. Mol. Genet. 21, 1744-1759 CrossRef PubMed
76. Loovers, H. M., Kortholt, A., de Groote, H., Whitty, L., Nussbaum, R. L. and van Haastert, P. J. M. (2007) Regulation of phagocytosis in Dictyostelium by the inositol 5-phosphatase OCRL homolog Dd5P4. Traffic 8, 618-628 CrossRef PubMed (Pubitemid 46638569)
77. Dambournet, D., Machicoane, M., Chesneau, L., Sachse, M., Rocancourt, M., El Marjou, A., Formstecher, E., Salomon, R., Goud, B. and Echard, A. (2011) Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis. Nat. Cell Biol. 13, 981-988 CrossRef PubMed
78. Ben El Kadhi, K., Roubinet, C., Solinet, S., Eméry, G. and Carréno, S. (2011) The Inositol 5-phosphatase dOCRL controls PI(4,5)P2 homeostasis and is necessary for cytokinesis. Curr. Biol. 21, 1074-1079 CrossRef PubMed
79. Grieve, A. G., Daniels, R. D., Sanchez-Heras, E., Hayes, M. J., Moss, S. E., Matter, K., Lowe, M. and Levine, T. P. (2011) Lowe syndrome protein OCRL1 supports maturation of polarized epithelial cells. PLoS ONE 6, e24044 CrossRef PubMed
80. Coon, B. G., Hernandez, V., Madhivanan, K., Mukherjee, D., Hanna, C. B., Barinaga-Rementeria Ramirez, I., Lowe, M., Beales, P. L. and Aguilar, R. C. (2012) The Lowe syndrome protein OCRL1 is involved in primary cilia assembly. Hum. Mol. Genet. 21, 1835-1847 CrossRef PubMed
81. Rbaibi, Y., Cui, S., Mo, D., Carattino, M., Rohatgi, R., Satlin, L. M., Szalinski, C. M., Swanhart, L. M., Fölsch, H., Hukriede, N. A. and Weisz, O. A. (2012) OCRL1 modulates cilia length in renal epithelial cells. Traffic 13, 1295-1305 CrossRef PubMed
82. Jackson, S. P., Schoenwaelder, S. M., Matzaris, M., Brown, S. and Mitchell, C. A. (1995) Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75-kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase. EMBO J. 14, 4490-4500 PubMed
83. Matzaris, M., Jackson, S. P., Laxminarayan, K. M., Speed, C. J. and Mitchell, C. A. (1994) Identification and characterization of the phosphatidylinositol-(4, 5)-bisphosphate 5-phosphatase in human platelets. J. Biol. Chem. 269, 3397-3402 PubMed
84. Williams, C., Choudhury, R., McKenzie, E. and Lowe, M. (2007) Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway. J. Cell Sci. 120, 3941-3951 CrossRef PubMed (Pubitemid 350269400)
85. Erdmann, K. S., Mao, Y., McCrea, H. J., Zoncu, R., Lee, S., Paradise, S., Modregger, J., Biemesderfer, D., Toomre, D. and De Camilli, P. (2007) A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev. Cell 13, 377-390 CrossRef PubMed (Pubitemid 47321603)
86. Bohdanowicz, M., Balkin, D. M., De Camilli, P. and Grinstein, S. (2012) Recruitment of OCRL and Inpp5B to phagosomes by Rab5 and APPL1 depletes phosphoinositides and attenuates Akt signaling. Mol. Biol. Cell 23, 176-187 CrossRef PubMed
87. Bohdanowicz, M., Cosío, G., Backer, J. M. and Grinstein, S. (2010) Class I and class III phosphoinositide 3-kinases are required for actin polymerization that propels phagosomes. J. Cell Biol. 191, 999-1012 CrossRef PubMed
88. Luo, N., Kumar, A., Conwell, M., Weinreb, R. N., Anderson, R. and Sun, Y. (2013) Compensatory role of inositol 5-phosphatase INPP5B to OCRL in primary cilia formation in oculocerebrorenal syndrome of Lowe. PLoS ONE 8, e66727 CrossRef PubMed
89. Hellsten, E., Bernard, D. J., Owens, J. W., Eckhaus, M., Suchy, S. F. and Nussbaum, R. L. (2002) Sertoli cell vacuolization and abnormal germ cell adhesion in mice deficient in an inositol polyphosphate 5-phosphatase. Biol. Reprod. 66, 1522-1530 CrossRef PubMed (Pubitemid 34462299)
90. Nemoto, Y., Arribas, M., Haffner, C. and DeCamilli, P. (1997) Synaptojanin 2, a novel synaptojanin isoform with a distinct targeting domain and expression pattern. J. Biol. Chem. 272, 30817-30821 CrossRef PubMed (Pubitemid 27527521)
91. Ramjaun, A. R. and McPherson, P. S. (1996) Tissue-specific alternative splicing generates two synaptojanin isoforms with differential membrane binding properties. J. Biol. Chem. 271, 24856-24861 CrossRef PubMed (Pubitemid 26333237)
92. Nemoto, Y., Wenk, M. R., Watanabe, M., Daniell, L., Murakami, T., Ringstad, N., Yamada, H., Takei, K. and De Camilli, P. (2001) Identification and characterization of a synaptojanin 2 splice isoform predominantly expressed in nerve terminals. J. Biol. Chem. 276, 41133-41142 CrossRef PubMed
93. Seet, L.-F., Cho, S., Hessel, A. and Dumont, D. J. (1998) Molecular cloning of multiple isoforms of synaptojanin 2 and assignment of the gene to mouse chromosome 17A2-3.1. Biochem. Biophys. Res. Commun. 247, 116-122 CrossRef PubMed (Pubitemid 28412536)
94. McPherson, P. S., Garcia, E. P., Slepnev, V. I., David, C., Zhang, X., Grabs, D., Sossini, W. S., Bauerfeind, R., Nemoto, Y. and De Camilli, P. (1996) A presynaptic inositol-5-phosphatase. Nature 379, 353-357 CrossRef PubMed (Pubitemid 26033932)
95. Perera, R. M., Zoncu, R., Lucast, L., De Camilli, P. and Toomre, D. (2006) Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages. Proc. Natl. Acad. Sci. U.S.A. 103, 19332-19337 CrossRef PubMed (Pubitemid 46026032)
96. Cremona, O., Di Paolo, G., Wenk, M. R., Lüthi, A., Kim, W. T., Takei, K., Daniell, L., Nemoto, Y., Shears, S. B., Flavell, R. A. et al. (1999) Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99, 179-188 CrossRef PubMed (Pubitemid 29491784)
97. Harris, T. W., Hartwieg, E., Horvitz, H. R. and Jorgensen, E. M. (2000) Mutations in synaptojanin disrupt synaptic vesicle recycling. J. Cell Biol. 150, 589-600 CrossRef PubMed
98. Mani, M., Lee, S. Y., Lucast, L., Cremona, O., Di Paolo, G., De Camilli, P. and Ryan, T. A. (2007) The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals. Neuron 56, 1004-1018 CrossRef PubMed (Pubitemid 350251112)
99. Arai, Y., Ijuin, T., Takenawa, T., Becker, L. E. and Takashima, S. (2002) Excessive expression of synaptojanin in brains with Down syndrome. Brain Dev. 24, 67-72 CrossRef PubMed (Pubitemid 34224905)
100. Cossec, J.-C., Lavaur, J., Berman, D. E., Rivals, I., Hoischen, A., Stora, S., Ripoll, C., Mircher, C., Grattau, Y., OlivoMarin, J.-C. et al. (2012) Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum. Mol. Genet. 21, 3156-3172 CrossRef PubMed
101. Berman, D. E., Dall'Armi, C., Voronov, S. V., McIntire, L. B. J., Zhang, H., Moore, A. Z., Staniszewski, A., Arancio, O., Kim, T.-W. and Di Paolo, G. (2008) Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5- bisphosphate metabolism. Nat. Neurosci. 11, 547-554 CrossRef PubMed (Pubitemid 351595195)
102. McIntire, L. B. J., Berman, D. E., Myaeng, J., Staniszewski, A., Arancio, O., Di Paolo, G. and Kim, T.-W. (2012) Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease. J. Neurosci. 32, 15271-15276 CrossRef PubMed
103. Zhu, L., Zhong, M., Zhao, J., Rhee, H., Caesar, I., Knight, E., Volpicelli-Daley, L., Bustos, V., Netzer, W., Liu, L. et al. (2013) Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model. J. Biol. Chem. 288, 32050-32063 CrossRef PubMed
104. Krebs, C. E., Karkheiran, S., Powell, J. C., Cao, M., Makarov, V., Darvish, H., Di Paolo, G., Walker, R. H., Shahidi, G. A., Buxbaum, J. D. et al. (2013) The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum. Mutat. 34, 1200-1207 CrossRef PubMed
105. Rusk, N., Le, P. U., Mariggio, S., Guay, G., Lurisci, C., Nabi, I. R., Corda, D. and Symons, M. (2003) Synaptojanin 2 functions at an early step of clathrin-mediated endocytosis. Curr. Biol. 13, 659-663 CrossRef PubMed (Pubitemid 36453314)
106. Malecz, N., McCabe, P. C., Spaargaren, C., Qiu, R.-G., Chuang, Y.-y. and Symons, M. (2000) Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis. Curr. Biol. 10, 1383-1386 CrossRef PubMed
107. Manji, S. S. M., Williams, L. H., Miller, K. A., Ooms, L. M., Bahlo, M., Mitchell, C. A. and Dahl, H.-H. M. (2011) A mutation in synaptojanin 2 causes progressive hearing loss in the ENU-mutagenised mouse strain Mozart. PLoS ONE 6, e17607 CrossRef PubMed
108. Kong, A. M., Speed, C. J., O'Malley, C. J., Layton, M. J., Meehan, T., Loveland, K. L., Cheema, S., Ooms, L. M. and Mitchell, C. A. (2000) Cloning and characterization of a 72-kDa inositol-polyphosphate 5-phosphatase localized to the Golgi network. J. Biol. Chem. 275, 24052-24064 CrossRef PubMed (Pubitemid 30627461)
109. Kisseleva, M. V., Wilson, M. P. and Majerus, P. W. (2000) The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. J. Biol. Chem. 275, 20110-20116 CrossRef PubMed (Pubitemid 30441622)
110. Kong, A. M., Horan, K. A., Sriratana, A., Bailey, C. G., Collyer, L. J., Nandurkar, H. H., Shisheva, A., Layton, M. J., Rasko, J. E. J., Rowe, T. and Mitchell, C. A. (2006) Phosphatidylinositol 3-phosphate [PtdIns(3)P ] is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns(3)P can promote GLUT4 translocation to the plasma membrane. Mol. Cell. Biol. 26, 6065-6081 CrossRef PubMed (Pubitemid 44204526)
111. Jacoby, M., Cox, J. J., Gayral, S., Hampshire, D. J., Ayub, M., Blockmans, M., Pernot, E., Kisseleva, M. V., Compere, P., Schiffmann, S. N. et al. (2009) INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41, 1027-1031 CrossRef PubMed
112. Bielas, S. L., Silhavy, J. L., Brancati, F., Kisseleva, M. V., Al-Gazali, L., Sztriha, L., Bayoumi, R. A., Zaki, M. S., Abdel-Aleem, A., Rosti, R. O. et al. (2009) Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41, 1032-1036 CrossRef PubMed
113. Horan, K. A., Watanabe, K.-i., Kong, A. M., Bailey, C. G., Rasko, J. E. J., Sasaki, T. and Mitchell, C. A. (2007) Regulation of Fcγ R-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3-mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup. Blood 110, 4480-4491 CrossRef PubMed (Pubitemid 351377815)
114. Luo, N., Lu, J. and Sun, Y. (2012) Evidence of a role of inositol polyphosphate 5-phosphatase INPP5E in cilia formation in zebrafish. Vision Res. 75, 98-107 CrossRef PubMed
115. Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. and Erneux, C. (1997) Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239, 697-700 CrossRef PubMed (Pubitemid 27504164)
116. Liu, Q., Shalaby, F., Jones, J., Bouchard, D. and Dumont, D. J. (1998) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP, is expressed during hematopoiesis and spermatogenesis. Blood 91, 2753-2759 PubMed (Pubitemid 28227525)
117. Bai, L. and Rohrschneider, L. R. (2010) s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev. 24, 1882-1892 CrossRef PubMed
118. Hamilton, M. J., Ho, V. W., Kuroda, E., Ruschmann, J., Antignano, F., Lam, V. and Krystal, G. (2011) Role of SHIP in cancer. Exp. Hematol. 39, 2-13 CrossRef PubMed
119. Kamen, L. A., Levinsohn, J. and Swanson, J. A. (2007) Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes. Mol. Biol. Cell 18, 2463-2472 CrossRef PubMed (Pubitemid 47025712)
120. Muraille, E., Dassesse, D., Vanderwinden, J. M., Cremer, H., Rogister, B., Erneux, C. and Schiffmann, S. N. (2001) The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience 105, 1019-1030 CrossRef PubMed (Pubitemid 32786814)
121. Taylor, V., Wong, M., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. and Stokoe, D. (2000) 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20, 6860-6871 CrossRef PubMed
122. Chi, Y., Zhou, B., Wang, W.-Q., Chung, S.-K., Kwon, Y.-U., Ahn, Y.-H., Chang, Y.-T., Tsujishita, Y., Hurley, J. H. and Zhang, Z.-Y. (2004) Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe synaptojanin and SHIP2. J. Biol. Chem. 279, 44987-44995 CrossRef PubMed (Pubitemid 39430912)
123. Nakatsu, F., Perera, R. M., Lucast, L., Zoncu, R., Domin, J., Gertler, F. B., Toomre, D. and De Camilli, P. (2010) The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics. J. Cell Biol. 190, 307-315 CrossRef PubMed
124. Prasad, N., Topping, R. S. and Decker, S. J. (2001) SH2-containing inositol 5-phosphatase SHIP2 associates with the p130Cas adapter protein and regulates cellular adhesion and spreading. Mol. Cell. Biol. 21, 1416-1428 CrossRef PubMed (Pubitemid 32114988)
125. Dyson, J. M., O'Malley, C. J., Becanovic, J., Munday, A. D., Berndt, M. C., Coghill, I. D., Nandurkar, H. H., Ooms, L. M. and Mitchell, C. A. (2001) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell Biol. 155, 1065-1080 CrossRef PubMed
126. Kato, K., Yazawa, T., Taki, K., Mori, K., Wang, S., Nishioka, T., Hamaguchi, T., Itoh, T., Takenawa, T., Kataoka, C. et al. (2012) The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol. Biol. Cell 23, 2593-2604 CrossRef PubMed
127. Prasad, N. K. (2009) SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells. Int. J. Oncol. 34, 97-105 PubMed
128. Prasad, N. K. and Decker, S. J. (2005) SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 280, 13129-13136 CrossRef PubMed
129. Zhuang, G., Hunter, S., Hwang, Y. and Chen, J. (2007) Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol
130. Ai, J., Maturu, A., Johnson, W., Wang, Y., Marsh, C. B. and Tridandapani, S. (2006) The inositol phosphatase SHIP-2 down-regulates Fcγ R-mediated phagocytosis in murine macrophages independently of SHIP-1. Blood 107, 813-820 CrossRef PubMed (Pubitemid 43076410)
131. Sleeman, M. W., Wortley, K. E., Lai, K.-M. V., Gowen, L. C., Kintner, J., Kline, W. O., Garcia, K., Stitt, T. N., Yancopoulos, G. D., Wiegand, S. J. and Glass, D. J. (2005) Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11, 199-205 CrossRef PubMed (Pubitemid 40321356)
132. Suwa, A., Kurama, T. and Shimokawa, T. (2010) SHIP2 and its involvement in various diseases. Expert Opin. Ther. Targets 14, 727-737 CrossRef PubMed
133. Ijuin, T., Mochizuki, Y., Fukami, K., Funaki, M., Asano, T. and Takenawa, T. (2000) Identification and characterization of a novel inositol polyphosphate 5-phosphatase. J. Biol. Chem. 275, 10870-10875 CrossRef PubMed (Pubitemid 30212720)
134. Gurung, R., Tan, A., Ooms, L. M., McGrath, M. J., Huysmans, R. D., Munday, A. D., Prescott, M., Whisstock, J. C. and Mitchell, C. A. (2003) Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization: the inositol 5-phosphatase SKIP localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation. J. Biol. Chem. 278, 11376-11385 CrossRef PubMed (Pubitemid 36792695)
135. Ijuin, T. and Takenawa, T. (2003) SKIP Negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol. Cell. Biol. 23, 1209-1220 CrossRef PubMed (Pubitemid 36177031)
136. Mochizuki, Y. and Takenawa, T. (1999) Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles. J. Biol. Chem. 274, 36790-36795 CrossRef PubMed
137. Ooms, L. M., Fedele, C. G., Astle, M. V., Ivetac, I., Cheung, V., Pearson, R. B., Layton, M. J., Forrai, A., Nandurkar, H. H. and Mitchell, C. A. (2006) The inositol polyphosphate 5-phosphatase, PIPP, is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol. Biol. Cell 17, 607-622 CrossRef PubMed (Pubitemid 43191097)
138. Denley, A., Gymnopoulos, M., Kang, S., Mitchell, C. and Vogt, P. K. (2009) Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation. Mol. Cancer Res. 7, 1132-1138 CrossRef PubMed
139. Laxminarayan, K. M., Matzaris, M., Speed, C. J. and Mitchell, C. A. (1993) Purification and characterization of a 43-kDa membrane-associated inositol polyphosphate 5-phosphatase from human placenta. J. Biol. Chem. 268, 4968-4974 PubMed (Pubitemid 23081619)
140. Speed, C. J., Neylon, C. B., Little, P. J. and Mitchell, C. A. (1999) Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with spontaneous calcium oscillations and enhanced calcium responses following endothelin-1 stimulation. J. Cell Sci. 112, 669-679 PubMed (Pubitemid 29141987)
141. Windhorst, S., Minge, D., Bähring, R., Huüser, S., Schob, C., Blechner, C., Lin, H.-Y., Mayr, G. W. and Kindler, S. (2012) Inositol-1,4,5-trisphosphate 3-kinase A regulates dendritic morphology and shapes synaptic Ca2+ transients. Cell. Signall. 24, 750-757 CrossRef
142. Kasumu, A. W., Liang, X., Egorova, P., Vorontsova, D. and Bezprozvanny, I. (2012) Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar Purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice. J. Neurosci. 32, 12786-12796 CrossRef PubMed
143. Konrad, G., Schlecker, T., Faulhammer, F. and Mayinger, P. (2002) Retention of the yeast Sac1p phosphatase in the endoplasmic reticulum causes distinct changes in cellular phosphoinositide levels and stimulates microsomal ATP transport. J. Biol. Chem. 277, 10547-10554 CrossRef PubMed (Pubitemid 34968178)
144. Nemoto, Y., Kearns, B. G., Wenk, M. R., Chen, H., Mori, K., Alb, J. G., De Camilli, P. and Bankaitis, V. A. (2000) Functional characterization of a mammalian sac1 and mutants exhibiting substrate-specific defects in phosphoinositide phosphatase activity. J. Biol. Chem. 275, 34293-34305 CrossRef PubMed
145. Whitters, E., Cleves, A., McGee, T., Skinner, H. and Bankaitis, V. (1993) SAC1p is an integral membrane protein that influences the cellular requirement for phospholipid transfer protein function and inositol in yeast. J. Cell Biol. 122, 79-94 CrossRef PubMed (Pubitemid 23188800)
146. Blagoveshchenskaya, A., Cheong, F. Y., Rohde, H. M., Glover, G., Knödler, A., Nicolson, T., Boehmelt, G. and Mayinger, P. (2008) Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1. J. Cell Biol. 180, 803-812 CrossRef PubMed (Pubitemid 351397779)
147. Schorr, M., Then, A., Tahirovic, S., Hug, N. and Mayinger, P. (2001) The phosphoinositide phosphatase Sac1p controls trafficking of the yeast Chs3p chitin synthase. Curr. Biol. 11, 1421-1426 CrossRef PubMed (Pubitemid 32863191)
148. Cheong, F. Y., Sharma, V., Blagoveshchenskaya, A., Oorschot, V. M. J., Brankatschk, B., Klumperman, J., Freeze, H. H. and Mayinger, P. (2010) Spatial regulation of Golgi phosphatidylinositol-4-phosphate is required for enzyme localization and glycosylation fidelity. Traffic 11, 1180-1190 CrossRef PubMed
149. Liu, Y., Boukhelifa, M., Tribble, E., Morin-Kensicki, E., Uetrecht, A., Bear, J. E. and Bankaitis, V. A. (2008) The Sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals. Mol. Biol. Cell 19, 3080-3096 CrossRef PubMed
150. Forrest, S., Chai, A., Sanhueza, M., Marescotti, M., Parry, K., Georgiev, A., Sahota, V., Mendez-Castro, R. and Pennetta, G. (2013) Increased levels of phosphoinositides cause neurodegeneration in a Drosophila model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 2689-2704 CrossRef PubMed
151. Zhang, L., Hong, Z., Lin, W., Shao, R.-X., Goto, K., Hsu, V. W. and Chung, R. T. (2012) ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication. PLoS ONE 7, e32135 CrossRef PubMed
152. Minagawa, T., Ijuin, T., Mochizuki, Y. and Takenawa, T. (2001) Identification and characterization of a Sac domain-containing phosphoinositide 5-phosphatase. J. Biol. Chem. 276, 22011-22015 CrossRef PubMed
153. Zhu, W., Trivedi, C. M., Zhou, D., Yuan, L., Lu, M. M. and Epstein, J. A. (2009) Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness. Circ. Res. 105, 1240-1247 CrossRef PubMed
154. Sbrissa, D., Ikonomov, O. C., Fu, Z., Ijuin, T., Gruenberg, J., Takenawa, T. and Shisheva, A. (2007) Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport: novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol. Chem. 282, 23878-23891 CrossRef PubMed (Pubitemid 47328041)
155. Yuan, Y., Gao, X., Guo, N., Zhang, H., Xie, Z., Jin, M., Li, B., Yu, L. and Jing, N. (2007) rSac3, a novel Sac domain phosphoinositide phosphatase, promotes neurite outgrowth in PC12 cells. Cell Res. 17, 919-932 CrossRef PubMed (Pubitemid 350126863)
156. Duex, J. E., Nau, J. J., Kauffman, E. J. and Weisman, L. S. (2006) Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3,5-bisphosphate levels. Eukaryot. Cell 5, 723-731 CrossRef PubMed
157. de Lartigue, J., Polson, H., Feldman, M., Shokat, K., Tooze, S. A., Urbé, S. and Clague, M. J. (2009) PIKfyve regulation of endosome-linked pathways. Traffic 10, 883-893 CrossRef PubMed
158. Ferguson, C. J., Lenk, G. M. and Meisler, M. H. (2009) Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum. Mol. Genet. 18, 4868-4878 CrossRef PubMed
159. Martyn, C. and Li, J. (2013) Fig4 deficiency: a newly emerged lysosomal storage disorder? Prog. Neurobiol. 101-102, 35-45
160. Ferguson, C. J., Lenk, G. M., Jones, J. M., Grant, A. E., Winters, J. J., Dowling, J. J., Giger, R. J. and Meisler, M. H. (2012) Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. Hum. Mol. Genet. 21, 3525-3534 CrossRef PubMed
161. Zhang, X., Chow, C. Y., Sahenk, Z., Shy, M. E., Meisler, M. H. and Li, J. (2008) Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 131, 1990-2001 CrossRef PubMed
162. Lenk, G. M., Ferguson, C. J., Chow, C. Y., Jin, N., Jones, J. M., Grant, A. E., Zolov, S. N., Winters, J. J., Giger, R. J., Dowling, J. J. et al. (2011) Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet. 7, e1002104 CrossRef PubMed
163. Chow, C. Y., Landers, J. E., Bergren, S. K., Sapp, P. C., Grant, A. E., Jones, J. M., Everett, L., Lenk, G. M., McKenna-Yasek, D. M., Weisman, L. S. et al. (2009) Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am. J. Hum. Genet. 84, 85-88 CrossRef PubMed
164. Campeau, P. M., Lenk, G. M., Lu, J. T., Bae, Y., Burrage, L., Turnpenny, P., Corona-Rivera, J. R., Morandi, L., Mora, M., Reutter, H. et al. (2013) Yunis-Varón syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase. Am. J. Hum. Genet. 92, 781-791 CrossRef PubMed
165. Kon, T., Mori, F., Tanji, K., Miki, Y., Toyoshima, Y., Yoshida, M., Sasaki, H., Kakita, A., Takahashi, H. and Wakabayashi, K. (2013) ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases. Neuropathology 34, 19-26 CrossRef PubMed
166. Weber, S. S., Ragaz, C. and Hilbi, H. (2009) Pathogen trafficking pathways and host phosphoinositide metabolism. Mol. Microbiol. 71, 1341-1352 CrossRef PubMed
167. Ham, H., Sreelatha, A. and Orth, K. (2011) Manipulation of host membranes by bacterial effectors. Nat. Rev. Microbiol. 9, CrossRef
168. Smith, K., Humphreys, D., Hume, P. J. and Koronakis, V. (2010) Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 7, 13-24 CrossRef PubMed
169. Sarantis, H., Balkin, D. M., De Camilli, P., Isberg, R. R., Brumell, J. H. and Grinstein, S. (2012) Yersinia entry into host cells requires Rab5-dependent dephosphorylation of PI(4,5)P2 and membrane scission. Cell Host Microbe 11, 117-128 CrossRef PubMed
170. Moorhead, A. M., Jung, J.-Y., Smirnov, A., Kaufer, S. and Scidmore, M. A. (2010) Multiple host proteins that function in phosphatidylinositol-4-phosphate metabolism are recruited to the chlamydial inclusion. Infect. Immun. 78, 1990-2007 CrossRef PubMed
171. Kühbacher, A., Dambournet, D., Echard, A., Cossart, P. and Pizarro-Cerdá, J. (2012) Phosphatidylinositol 5-phosphatase oculocerebrorenal syndrome of Lowe protein (OCRL) controls actin dynamics during early steps of Listeria monocytogenes infection. J. Biol. Chem. 287, 13128-13136 CrossRef PubMed
172. Weber, S. S., Ragaz, C. and Hilbi, H. (2009) The inositol polyphosphate 5-phosphatase OCRL1 restricts intracellular growth of Legionella, localizes to the replicative vacuole and binds to the bacterial effector LpnE. Cell. Microbiol. 11, 442-460 CrossRef PubMed
173. Niebuhr, K., Giuriato, S., Pedron, T., Philpott, D. J., Gaits, F., Sable, J., Sheetz, M. P., Parsot, C., Sansonetti, P. J. and Payrastre, B. (2002) Conversion of PtdIns(4,5)P2 into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 5069-5078 CrossRef PubMed
174. Ramel, D., Lagarrigue, F., Pons, V., Mounier, J., Dupuis-Coronas, S., Chicanne, G., Sansonetti, P. J., Gaits-Iacovoni, F., Tronchere, H. and Payrastre, B. (2011) Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Sci. Signal. 4, ra61 CrossRef PubMed
175. Norris, F. A., Wilson, M. P., Wallis, T. S., Galyov, E. E. and Majerus, P. W. (1998) SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc. Natl. Acad. Sci. U.S.A. 95, 14057-14059 CrossRef PubMed (Pubitemid 28549319)
176. Marcus, S. L., Wenk, M. R., Steele-Mortimer, O. and Finlay, B. B. (2001) A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation. FEBS Lett. 494, 201-207 CrossRef PubMed (Pubitemid 32322683)
177. Hernandez, L. D., Hueffer, K., Wenk, M. R. and Galán, J. E. (2004) Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304, 1805-1807 CrossRef PubMed (Pubitemid 38787897)
178. Vergne, I., Chua, J., Lee, H.-H., Lucas, M., Belisle, J. and Deretic, V. (2005) Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 102, 4033-4038 CrossRef PubMed (Pubitemid 40388550)
179. Balla, T., Szentpetery, Z. and Kim, Y. J. (2009) Phosphoinositide signaling: new tools and insights. Physiology 24, 231-244 CrossRef PubMed
180. Idevall-Hagren, O., Dickson, E. J., Hille, B., Toomre, D. K. and De Camilli, P. (2012) Optogenetic control of phosphoinositide metabolism. Proc. Natl. Acad. Sci. U.S.A. 109, E2316-E2323 CrossRef PubMed
181. Tronchère, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L., Mandel, J.-L. and Payrastre, B. (2004) Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J. Biol. Chem. 279, 7304-7312 PubMed
182. Jean, S., Cox, S., Schmidt, E. J., Robinson, F. L. and Kiger, A. (2012) Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling. Mol. Biol. Cell 23, 2723-2740 CrossRef PubMed
183. Zou, J., Marjanovic, J., Kisseleva, M. V., Wilson, M. and Majerus, P. W. (2007) Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis. Proc. Natl. Acad. Sci. 104, 16834-16839 CrossRef (Pubitemid 350210951)
184. Taguchi-Atarashi, N., Hamasaki, M., Matsunaga, K., Omori, H., Ktistakis, N. T., Yoshimori, T. and Noda, T. (2010) Modulation of local PtdIns3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy. Traffic 11, 468-478 CrossRef PubMed
185. Sanchez-Juan, P., Bishop, M. T., Aulchenko, Y. S., Brandel, J.-P., Rivadeneira, F., Struchalin, M., Lambert, J.-C., Amouyel, P., Combarros, O., Sainz, J. et al. (2012) Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol. Aging 33, 1487.e1421-1487.e1428 CrossRef
186. Berger, P., Berger, I., Schaffitzel, C., Tersar, K., Volkmer, B. and Suter, U. (2006) Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum. Mol. Genet. 15, 569-579 CrossRef PubMed (Pubitemid 43205422)
187. Azzedine, H., Bolino, A., Taïeb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T. et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72, 1141-1153 CrossRef PubMed (Pubitemid 36530002)
188. Yang, G., Zhou, X., Zhu, J., Liu, R., Zhang, S., Coquinco, A., Chen, Y., Wen, Y., Kojic, L., Jia, W. and Cynader, M. S. (2013) JNK3 couples the neuronal stress response to inhibition of secretory trafficking. Sci. Signal. 6, ra57 PubMed
189. Pirruccello, M., Nandez, R., Idevall-Hagren, O., Alcazar-Roman, A., Abriola, L., Berwick, S., Lucast, L., Morel, D. and De Camilli, P. (2014) Identification of inhibitors of inositol 5-phosphatases through multiple screening strategies. ACS Chem. Biol., doi:10.1021/cb500161z CrossRef